Company page

Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc. (ticker: BZYR) is a public company based in the United States, with a market capitalization of approximately $1.42 million. The company is focused on research and development in the field of cancer treatment. As a publicly traded entity, it operates within the American market, providing opportunities for investors interested in biotechnology and healthcare advancements.